Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Gross Margin

Amneal Pharmaceuticals Inc Gross Margin Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Gross Margin from 2016 to 2018. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Amneal Pharmaceuticals Inc Gross Margin for the quarter ending December 12, 2018 was $38m a -42.00% decrease of -16m year over year
  • Amneal Pharmaceuticals Inc Gross Margin for the last 12 months ending December 12, 2018 was $42m a -29.59% decrease of -12m year over year
  • Amneal Pharmaceuticals Inc Annual Gross Margin for 2018 was $42m a -27.92% decrease of -12m from 2017
  • Amneal Pharmaceuticals Inc Annual Gross Margin for 2017 was $54m a -7.60% decrease of -4m from 2016
  • Amneal Pharmaceuticals Inc Annual Gross Margin for 2016 was $58m a 0.55% increase of 0m from 2015
Other Margins & Efficiency Metrics:
  • Amneal Pharmaceuticals Inc EBITDA Margin for the quarter ending December 12, 2018 was $22m a -41.75% decrease of -9m year over year
  • Amneal Pharmaceuticals Inc Return on Capital % for the quarter ending December 12, 2018 was 4.18 a -281.33% decrease of -11.75 year over year
  • Amneal Pharmaceuticals Inc Return on Equity % for the quarter ending December 12, 2018 was -8.98
View Chart On Koyfin

Quarterly AMRX Gross Margin Data

12/2018$38m
09/2018$45m
06/2018$42m
03/2018$54m
12/2017$55m
09/2017$50m
06/2017$46m
03/2017$51m
12/2016$59m

Annual AMRX Gross Margin Data

2018$42m
2017$54m
2016$58m
2015$58m
2014$57m